Abstract:Introduction: Porcine NICC xenotransplantation has been proposed as a novel treatment of type 1 diabetes. However T-cell-mediated rejection remains a major impediment to its clinical application. The ability to manufacture xenoantigen-specific Treg may be a strategy to achieve effective suppression. Previously, we identified a HLA-DR+CD27+ subset of Treg that was separated from xenoantigen-stimulated human Treg (XnTreg) and showed potent and xenoantigen-specific suppression in vitro. The aim of this study was to confirm their suppressive function and antigen specificity in vivo. Methods: Human Treg isolated from healthy donor peripheral blood mononuclear cells were expanded for 3 or 4 cycles with anti-CD3/CD28 beads and irradiated porcine PBMC as xenoantigen to produce antigen-stimulated Treg (XnTreg). Human XnTreg were separated by cell sorting using the Treg cell surface markers CD27 and HLADR into non-selected XnTreg, HLADR+CD27+ and HLADR+CD27+ depleted-Treg (Dep-Treg) subsets prior to cotransfer into NOD-SCID IL2rg-/- mice recipients of porcine NICC with autologous PBMC and Treg at a 1:25 ratio of Treg (4x10^5): PBMC (1x10^7). Serum, spleen and NICC xenografts were harvested from recipient mice at day 60 for analysis of xenograft survival and Treg function in vivo. Results: Human PBMC engraftment was confirmed by flow cytometry by day 60 after adoptive transfer. Mice reconstituted with human PBMC without Treg rejected their xenografts completely within 35 days. However, in mouse recipients of NICC xenografts that were reconstituted with human PBMC and HLADR+CD27+ Treg, immunohistochemical analysis revealed more intact NICC grafts and insulin positive-staining compared to those reconstituted with non-selected Xn Treg group at day 60. In the Dep-Treg group, very few insulin positive-staining cells were seen and a large number of human CD4 and CD8 Tcells infiltrated the islet graft. However in HLADR+CD27+Treg group there were few CD4 and CD8 cells surrounding but not infiltrating the islet graft. The highest serum c-peptide levels were found in the HLADR+CD27+ Treg (458.83±78.1 pmol/l) transferred group compared to Xn-Treg (196.3±76.8 pmol/l), Dep-Treg (123.4±46.5 pmol/l) or Pc-Treg (144.1±19.0 pmol/l) transferred groups. Immunofluorescent showed that HLADR+CD27+ Treg mediated islet xenograft protection was associated with a larger proportion of intragraft CD4+Foxp3+ Treg. Furthermore, the TaqMan Low Density Array analysis of human immune gene expression demonstrated upregulated expression of the Treg functional molecues (CTLA-4 and IL10) along with downregulated proinflammatory gene expression in mice co-transferred with HLADR+CD27+ Treg and PBMC. Conclusion: CD27+HLADR+ Treg were more potent than naïve Treg at preventing islet xenograft rejection and could be achieved at much smaller Treg:Tcell ratios suggesting they may be more specific for the xenograft and may have potential as an effective immunomodulatory cell therapy for transplantation. NSFC81201171, Hunan Provincial Natural Science Foundation of China 2017JJ3423.

CD86 Blockade in Genetically Modified Porcine Cells Delays Xenograft Rejection by Inhibiting T-Cell and NK-Cell Activation

Strategies to induce natural killer cell tolerance in xenotransplantation

The Role of NK Cells in Pig-to-Human Xenotransplantation

Antibody-mediated rejection in xenotransplantation: Can it be prevented or reversed?

Co-expression of HLA-E and HLA-G on genetically modified porcine endothelial cells attenuates human NK cell-mediated degranulation

Porcine PD-L1: cloning, characterization, and implications during xenotransplantation

Rejection of porcine islet xenografts mediated by CD4+ T cells activated through the indirect antigen recognition pathway

Role for CD47-SIRPα Signaling in Xenograft Rejection by Macrophages

IDENTIFICATION AND ISOLATION OF HUMAN HLADR+CD27+TREG AS XENO-ANTIGEN TREG SUBSET FOR XENOTRANSPLANTATION

Increased soluble CD154 (CD40 ligand) levels in xenograft recipients correlate with the development of de novo anti-pig IgG antibodies

Potential Antigens Involved in Delayed Xenograft Rejection in a Ggta1/Cmah Dko Pig-to-Monkey Model

Human anti-pig NK cell and CD8+ T-cell responses in the presence of regulatory dendritic cells

Prolonged xenokidney graft survival in sensitized NHP recipients by expression of multiple human transgenes in a triple knockout pig

T Cells from Presensitized Donors Fail to Cause Graft-versus-Host Disease in a Pig-to-Mouse Xenotransplantation Model

Anti-CD40 antibody-mediated costimulation blockade promotes long-term survival of deep-lamellar porcine corneal grafts in non-human primates

Circulating Pig-Specific Dna As A Novel Biomarker For Monitoring Xenograft Rejection

Inhibiting T-Cell-Mediated Rejection of the Porcine Meniscus Through Freeze-Thawing and Downregulating Porcine Xenoreactive Antigen Genes

Xenoantigen Deletion and Chemical Immunosuppression Can Prolong Renal Xenograft Survival

A Potential Role of TLR2 in Xenograft Rejection of Porcine Iliac Endothelial Cells: an in Vitro Study

Early immune mechanisms of neonatal porcine islet xenograft rejection

Generation of GGTA1-/-β2M-/-CIITA-/- Pigs Using CRISPR/Cas9 Technology to Alleviate Xenogeneic Immune Reactions